Marea Therapeutics
33 employees
Biotech/Pharma
Series B · $190.0M
Open positions (1)
Company details
Team Size33
IndustryBiotech/Pharma
Funding
Total raised
$190.0M
Last stage
Series B
Investors
Forbion
Total raised
$190.0M
Last stage
Series B
Investors
Josh Lehrer
MD, M.Phil., FACC. CEO of Marea since October 2023. Previously CEO of Graphite Bio (merged with LENZ Therapeutics) and held leadership roles at Global Blood Therapeutics.
Ethan J. Weiss
MD. Scientific co-founder and CSO of Marea Therapeutics. Quoted as co-founder and CSO in multiple press releases and company announcements.
Joshua Rabinowitz
MD, PhD. Professor of Chemistry & Integrative Genomics at Princeton University. Scientific co-founder of Marea Therapeutics.
No applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.